Life Sciences

Gottlieb ends FDA hiring freeze, lays out R&D priorities

May 26, 2017

Scott Gottlieb, M.D., has ended the hiring freeze President Donald Trump imposed on the FDA. The action means FDA commissioner Gottlieb can fill vacancies to shape an agency capable of enacting his plans for how safety and efficacy information are gathered during development. Trump imposed..

Another top Biogen executive stepping down

May 26, 2017

Biogen, the state’s largest local drug company by market cap and headcount, is about to lose yet another top executive. Kenneth DiPietro plans to step down as executive vice president of human resources tomorrow, a spokesman for the Cambridge drugmaker told the Boston Business Journal..

Four more Alexion execs exit

May 25, 2017

Alexion has announced that four members of the company’s C-suite team are set to leave the company, following an internal investigation into sales practices. Chief financial officer Dave Anderson is among the casualties, who while just joining the company this past December is set to..

Ansell sells condom division to Chinese consortium for $800 million

May 25, 2017

After 112-years of Australian ownership Ansell will sell its condom business to a Chinese consortium for $800 million. Ansell says the time is right to exit the fluctuating sexual wellness market and focus on rubber gloves. Ansell’s history dates back to 1905, when Eric Norman..

Which pharma execs win the popularity contest?

May 24, 2017

Sometimes adult life sends us through a disturbing time warp. It’s much too reminiscent of high school. The cool kids’ cafeteria table (or parking lot, where I grew up) becomes the cool grown-up party at J.P. Morgan, for instance. Step into biopharma Twitter, where the..

Novartis to sever 250 U.S. workers

May 24, 2017

Just days after announcing plans to ax 500 jobs in Switzerland, Novartis said another 250 jobs will be eliminated in the U.S., most at its headquarters in New Jersey with some of those headed to a service center in India. The company filed a WARN..

Donald Trump’s healthcare budget outlines FDA, NIH cuts

May 24, 2017

President Donald Trump’s administration has released a breakdown of its attempts to cut back on healthcare and research spending across the government, with proposed cuts to governmental biomedical research centers and the drugs regulator laid down in the fleshed-out budget. The document (available via the..

Bioverativ to buy True North for $400M upfront

May 24, 2017

Bioverativ has struck a deal to buy True North Therapeutics. The deal will see the Biogen spinout pay $400 million upfront and up to $425 million in milestones to acquire the rare disease biotech and its clinical-phase treatment for cold agglutinin disease (CAD), TNT009. If..

House cleaning to re-Shape Alexion?

May 24, 2017

Alexion Pharmaceuticals Inc. continues to reshape its top-level management after the company was hit by an internal investigation into its sales practices. Alexion will start a search for a new Chief Financial Officer after current CFO Dave Anderson announced he will resign at the end..

Nevada bill could force Sanofi, Novo and Lilly to reveal their insulin pricing secrets

May 23, 2017

As a variety of states weigh measures targeting pharmaceutical pricing, Nevada’s Senate has passed a tough new bill that would publicly spotlight insulin makers’ price hikes and profits. Approved by the Nevada Senate on Friday, the bill would force diabetes drugmakers to disclose information on..